Learn more and register for AUTISM ONE in Chicago, Illinois May 24-30.
150 STRONG & THE MOST COMPREHENSIVE ROSTER OF SPEAKERS EVER ASSEMBLED TO HELP WITH AUTISM, NEUROIMMUNE, AND RELATED ISSUES
Wednesday, May 26: 8 am - noon
The National Autism Association Presents: The Restraint and Seclusion Prevention Symposium
The Restraint and Seclusion Prevention Symposium will cover all facets of the R&S issue. From introducing the basic understanding of restraint and seclusion to discussing how to address the issue in your child’s IEP, presenters will offer applicable and useful information to help you preserve your child’s rights, protect your child from harmful restraint and seclusion practices, and provide materials designed to increase your child’s protection in the school setting. Presenters will also provide invaluable tips on how to spot signs of abuse in your child and students, how teachers and aides can prevent dangerous situations in the classroom, and how you can help with federal and state legislative efforts. Take-home reference materials will be provided. Visit our friends at NAA: www.nationalautism.org.
Thursday, May 27: 9 am - 5 pm
The Elizabeth Birt Center for Autism Law and Advocacy presents a day of autism legal and advocacy training with Dr. Andrew Wakefield and Dr. Arthur Krigsman (EBCALA Keynotes); Mary Holland, JD; Jennifer Keefe, JD; Robert Krakow, JD; William Long, JD, PhD, MDiv; and more!
Friday, May 28: 8 am - 2:45 pm
Prediction and Prevention of ASD: Signs to watch out for and treatments that will help you avoid the diagnosis of autism
Dave Humphrey, JD, Kenneth Bock, MD, Martha Herbert, MD, PhD, Doreen Granpeesheh, PhD, BCBA-D, Kendal Stewart, MD, and Lisa Hunter Ryden, MT, MBA, will take attendees through a 5-part series emphasizing the importance of early detection of the symptoms of ASD as helping practitioners alter the course of diagnosis. With early detection, practitioners can identify treatment strategies and interventions that, when provided intensively, can prevent children from developing the full symptom criteria of autism. These red flags and treatment options will be reviewed. The speakers will include data from young siblings of children with autism illustrating that children who receive treatment at a very early age do, in fact, avoid receiving an ASD diagnosis as their symptoms are effectively reversed. Here's just a sample:
Autism in Infancy: Predetermined or Produced by Active Treatable Processes? presented by Martha Herbert, MD, PhD
Is autism stamped into the brain by genes from conception? Or does it develop? If it develops, what influences that development? And how can we influence those influences? If the brain isn't indelibly stamped with autism, then what happens to it to transform it so that it starts producing autistic behaviors? At what range of prenatal or postnatal ages might this start? Is there any way of detecting those changes in living babies? If we can head off the emergence of the debilitating features of autism, how can we prove we did this if we can't be sure ahead of time whether this might be where a baby is headed? Does it matter whether our measures are specific for autism or not? How can we make medical screening and prevention measures the standard of care? What would we need to demonstrate to make this happen, and how would we do this most powerfully? What are the biggest obstacles we would need to overcome? What would population-wide health-promotion and health-protection measures look like? What would be the most efficient and effective ways to carry this out? How much is our success in this a function of how well we answer the above questions?
Saturday, May 29, 3 pm
Judy Mikovits, PhD, presents:
Chronic fatigue syndrome (CFS) and autism spectrum disorder (ASD) share common clinical features including immune dysregulation, increased oxidative stress, increased expression of proinflammatory cytokines and chemokines, mitochondrial dysfunction and chronic active microbial infections suggesting an underlying immune deficiency may be involved in subgroups of CFS and ASD. We recently demonstrated the first direct isolation of an infectious gammaretrovirus, XMRV, from the blood of CFS patients. We have developed quantitative assays to detect XMRV replication and infection in cell culture. Moreover, we found evidence of XMRV infection in >85% of more than 200 CFS patients tested to date. These data implicate a role for XMRV infection in the pathogenesis of CFS. Because of the clinical similarities of CFS and ASD, we hypothesized that XMRV infection may also be detected in subgroups of ASD. This presentation will update the status of XMRV research, show evidence of XMRV infection in ASD and discuss the implications of XMRV infection in the pathogenesis of neuroimmune disease including ASD.
And . . . . at a special time yet to be announced:
The Age of Autism Editors and Andrew Wakefield!
This session will focus on how "The Daily Web Newspaper of the Autism Epidemic" is covering key stories and fighting to balance coverage that is regularly skewed by the mainstream media. No story has been more important -- or more skewed -- than Andrew Wakefield's General Medical Council Hearing, followed by the Lancet MMR study retraction. Editor Dan Olmsted, Managing Editor Kim Stagliano, and Editor at Large Mark Blaxill will discuss AOA's mission in the coming year and discuss with Andy how to continue to tell the truth about autism. Special guests include several AoA Contributing Editors.
HOPE IS ALWAYS REAL . . . . RECOVERY IS HAPPENING